Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
T Max |
1.8 |
h |
1.5-2 |
h |
Oral multiple dose; CYP2D6 genetic polymorphisms; extensive metabolizers, EM; |
DRUGBANK |
Clearance |
88.0 |
L/h |
88.0 |
L/h |
CYP2D6 genetic polymorphisms; |
DRUGBANK |
Clearance |
1.3 |
L/h/kg |
20.95 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
835.0 |
L |
835.0 |
L |
CYP2D6 genetic polymorphisms; |
DRUGBANK |
Half-life |
6.5 |
h |
6.5 |
h |
extensive metabolizers, EM; |
DRUGBANK |
Half-life |
8.9 |
h |
8.9 |
h |
poor metabolizers, PM; |
DRUGBANK |
Half-life |
7.7 |
h |
7.7 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
41.8 |
% |
41.8 |
% |
Urinary excretion; PO, oral; |
DRUGBANK |
Eliminate Route |
51.4 |
% |
51.4 |
% |
Faeces excretion; PO, oral; |
DRUGBANK |
Protein Binding |
79.5 |
% |
76-83 |
% |
|
DRUGBANK |